Glenmark Hit With $50M Suit Over Potassium Pill Death

By Mike Curley

A proposed class of buyers is suing Glenmark Pharmaceuticals Inc. for more than $50 million, alleging that the company's extended-release potassium chloride capsules are defective and instead deliver the potassium too fast, which resulted in the death of the lead plaintiff's mother.

 Complaint attached | Read full article » | Save to favorites »